Caregen
Financials
Valuation Metrics
Caregen's Market Cap is ₩2.0T. At end of 2025 it was ₩3.9T. Ranked #205 of 2,414 in KR market (top 8%), #41 of 1,633 on KOSDAQ (top 3%), #18 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 8%) by Market Cap.
Investment Metrics(as of 2026-10-15)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 2.00T KRW | KR#205/2,414 Sec#18/231 |
| Revenue | 74.90B KRW | KR#1,582/2,414 Sec#102/231 |
| Net Income | 22.87B KRW | KR#655/2,414 Sec#43/231 |
| Total Assets | 231.27B KRW | KR#1,207/2,414 Sec#86/231 |
| Net Assets | 212.47B KRW | KR#912/2,414 Sec#64/231 |
| Employees | 193 | KR#1,124/2,414 Sec#92/231 |
| Value | ||
| P/E | 87.24x | KR#1,485/2,414 Sec#98/231 |
| P/B | 9.39x | KR#2,355/2,414 Sec#211/231 |
| P/S | 26.64x | KR#2,349/2,414 Sec#190/231 |
| EV/EBITDA | 108.92x | KR#1,504/2,414 Sec#99/231 |
| FCF Yield | 0.74% | KR#1,163/2,414 Sec#86/231 |
| Profitability | ||
| ROE | 10.77% | KR#556/2,414 Sec#37/231 |
| ROA | 9.89% | KR#278/2,414 Sec#22/231 |
| Op. Margin | 24.35% | KR#104/2,414 Sec#14/231 |
| Revenue Growth | -7.63% | KR#1,862/2,414 Sec#175/231 |
| Earnings Growth | -23.73% | KR#949/2,414 Sec#61/231 |
| Financial Health | ||
| Debt Ratio | 8.85% | KR#117/2,414 Sec#24/231 |
| Total Debt | 0 KRW | KR—/2,414 Sec—/231 |
| FCF | 14.73B KRW | KR#608/2,414 Sec#32/231 |
| Cash | 8.86B KRW | KR#1,758/2,414 Sec#155/231 |
| Current Ratio | 7.93x | KR#146/2,414 Sec#30/231 |
| Net Debt/EBITDA | -0.49x | KR#496/2,414 Sec#30/231 |
| Dividend | ||
| Div. Yield | 1.18% | KR#1,090/2,414 Sec#63/231 |
| Div. Growth | -31.72% | KR—/2,414 Sec—/231 |
| Performance | ||
| 1Y Return | -40.56% | KR#1,772/2,414 Sec#155/231 |
| 1M Return | -9.72% | KR#1,524/2,414 Sec#151/231 |
| From 52W High | -75.85% | KR#2,237/2,414 Sec#199/231 |
| 1Y MDD | -75.25% | KR#2,172/2,414 Sec#190/231 |
| Trading | ||
| Volume | 63,376 shares | KR#1,215/2,414 Sec#124/231 |
| Trading Value | 2.36B KRW | KR#544/2,414 Sec#54/231 |
| Foreign Own. | 4.68% | KR#914/2,414 Sec#81/231 |
| Per Share | ||
| EPS | 426 KRW | KR#1,053/2,414 Sec#74/231 |
| BPS | 3,956 KRW | KR#1,690/2,414 Sec#123/231 |
Company Info
Caregen, established in 2001 and listed on KOSDAQ in 2015, is a biotechnology company headquartered in Gangnam-gu, Seoul. It researches and develops peptides and growth factor proteins, selling professional therapy products, functional cosmetics, and health functional foods in 130 countries. The company has built a peptide library with 833 domestic and international patent registrations and is developing new drug pipelines for conditions like macular degeneration, diabetes, and hair loss. Caregen is also expanding its business into new areas such as specialized animal pharmaceuticals and functional feeds.